本页面由Tiger Trade Technology Pte. Ltd.提供服务

Protagonist Therapeutics Inc

144.55
-0.3300-0.23%
成交量:2.32万
成交额:336.44万
市值:93.54亿
市盈率:140.34
高:146.00
开:146.00
低:143.57
收:144.88
52周最高:160.81
52周最低:73.08
股本:6,470.83万
流通股本:6,316.60万
量比:2.14
换手率:0.04%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
净资产收益率:10.98%
总资产收益率:4.55%
市净率:11.11
市盈率(LYR):-70.51

数据加载中...

2024/02/27

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

重要事件披露

Form 8-K - Current report
2024/01/16

重要事件披露

Form 8-K - Current report
2024/01/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2023/12/19

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/12/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/02

重要事件披露

Form 8-K - Current report
2023/10/31

重要事件披露

Form 8-K - Current report
2023/08/03

重要事件披露

Form 8-K - Current report